NCT07532798

Brief Summary

This study is about a treatment for a jaw condition called temporomandibular joint (TMJ) subluxation. In this condition, the jaw can move too far forward during mouth opening, which may cause repeated jaw locking and problems with normal function. The treatment being studied is platelet-rich plasma (PRP) injections. PRP is made from a person's own blood and may help improve joint stability and reduce symptoms. In this study, 40 adults with TMJ subluxation were randomly assigned to receive PRP with either a lower or higher platelet concentration. Each participant received 2 injections, given 2 weeks apart. The study measured jaw pain, how often locking happened, mouth opening, and joint clicking before treatment, after 6 months, and after 5 years. The goal of this study is to find out whether the amount of platelets in PRP changes how well this treatment works.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
8.8 years until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 16, 2026

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 2, 2026

Last Update Submit

April 9, 2026

Conditions

Keywords

TMJ subluxationTemporomandibular joint subluxationTMJ hypermobilityRecurrent TMJ dislocationPlatelet-rich plasmaPRP prolotherapy

Outcome Measures

Primary Outcomes (2)

  • TMJ Pain on Function

    Pain during jaw function measured using a visual analog scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates worst pain.

    Baseline, 6 months, and 5 years

  • Frequency of TMJ locking

    Frequency of locking, expressed as number of episodes per day

    Baseline, 6 months, and 5 years

Secondary Outcomes (2)

  • Maximum mouth opening (MMO)

    Baseline, 6 months, and 5 years

  • Presence of joint clicking

    Baseline, 6 months, and 5 years

Study Arms (2)

Low Platelet Concentration PRP (L-PRP)

ACTIVE COMPARATOR

Patients received prolotherapy using platelet-rich plasma with low platelet concentration.

Procedure: Low Platelet Concentration PRP (L-PRP)

High Platelet Concentration PRP (H-PRP)

ACTIVE COMPARATOR

Patients received prolotherapy using platelet-rich plasma with high platelet concentration.

Procedure: High Platelet Concentration PRP (L-PRP)

Interventions

Intra-articular and pericapsular injection of platelet-rich plasma prepared with Low platelet concentration..

Low Platelet Concentration PRP (L-PRP)

Intra-articular and pericapsular injection of platelet-rich plasma prepared with high platelet concentration.

High Platelet Concentration PRP (H-PRP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Hamida Refai, PhD

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors were blinded to group allocation. The clinician performing the intervention was not blinded due to the nature of the procedure.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Prosthodontics

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 16, 2026

Study Start

April 1, 2016

Primary Completion

January 1, 2017

Study Completion

July 1, 2017

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to institutional regulations and ethical considerations regarding patient confidentiality and data protection.

Locations